CAR-iNKT cells for cancer therapy: a comprehensive review of engineering, mechanisms, and clinical progress. [PDF]
Yang Y, Gu J, Ding Y, Li Y, Sun Z.
europepmc +1 more source
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural Mesothelioma. [PDF]
Li YR +13 more
europepmc +1 more source
Facts and Hopes of Chimeric Antigen Receptor-Redirected NK T Cells. [PDF]
Courtney AN +5 more
europepmc +1 more source
T helper 17 cells and group 3 innate lymphoid cells define a spectrum of psoriasis endotypes. [PDF]
Schön MP.
europepmc +1 more source
Role of Donor Unrestricted T Cells (DURTs) in TB Host Defense: Implications for Novel TB Vaccine Development. [PDF]
Kain D, Lewinsohn DM, Lewinsohn DA.
europepmc +1 more source
CD1d And CD1d-Restricted iNKT-Cells Play a Pivotal Role in Contact Hypersensitivity
CD1d-restricted T-cells are activated by glycolipids presented by the major histocompatibility complex class-Ib molecule CD1d, found on the surface of antigen-presenting cells (APC).
Silke Gillessen +2 more
exaly +8 more sources
Impaired Cell Surface Expression of Human CD1d by the Formation of an HIV-1 Nef/CD1d Complex
The HIV-1 Nef protein causes a decrease in major histocompatibility complex (MHC) class I and CD4 molecule expression on the cell surface. To determine if Nef can affect components of the innate immune response, we assessed the ability of Nef to alter the cell surface expression of human CD1d.
Johnny J. He +2 more
exaly +3 more sources
CD1d Expression on B-Precursor Acute Lymphoblastic Leukemia Subsets With Poor Prognosis
Acute lymphoblastic leukemia (ALL) is the most frequent malignancy of childhood. Although therapeutical advances have been achieved, some ALL subgroups still fare poorly. CD1d is a monomorphic molecule that provides a suitable target for immunotherapy in
Davide Bagnara +2 more
exaly +2 more sources

